Loading...
Dernières publications
-
Liem Nguyen, Maud Lemoine, Gibril Ndow, Zachary Ward, Timothy Hallet, et al.. Treat All versus targeted strategies to select HBV-infected people for antiviral therapy in The Gambia, west Africa: a cost-effectiveness analysis. The Lancet global health, 2024, 12 (1), pp.e66-e78. ⟨10.1016/S2214-109X(23)00467-9⟩. ⟨pasteur-04363873⟩
-
Luc Jaulmes, Youri Yordanov, Alexandre Descamps, Isabelle Durand-Zaleski, Aurélien Dinh, et al.. Effectiveness and Medicoeconomic Evaluation of Home Monitoring of Patients With Mild COVID-19: Covidom Cohort Study. Journal of Medical Internet Research, 2023, 25, pp.e43980. ⟨10.2196/43980⟩. ⟨hal-04142340⟩
-
Christiana Kartsonaki, J Kenneth Baillie, Noelia García Barrio, Joaquín Baruch, Abigail Beane, et al.. Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19. International Journal of Epidemiology, 2023, 52 (2), pp.355-376. ⟨10.1093/ije/dyad012⟩. ⟨hal-04164628⟩
-
Paul Loubet, Linda Wittkop, Laetitia Ninove, Mathieu Chalouni, Benoit Barrou, et al.. One-month humoral response following two or three doses of mRNA Covid-19 vaccines as primary vaccination in specific populations in France: first results from the ANRS0001S COV-POPART cohort. Clinical Microbiology and Infection, 2023, 29 (3), pp.388.e1-388.e8. ⟨10.1016/j.cmi.2022.10.009⟩. ⟨hal-03822592⟩
-
Jade Ghosn, Delphine Bachelet, Marine Livrozet, Minerva Cervantes-Gonzalez, Julien Poissy, et al.. Prevalence of Post-Acute COVID-19 Symptoms Twelve Months after Hospitalisation in Participants Retained in Follow-up: Analyses Stratified by Gender from a Large Prospective Cohort. Clinical Microbiology and Infection, 2023, 29 (2), pp.254.e7-254.e13. ⟨10.1016/j.cmi.2022.08.028⟩. ⟨hal-03801797⟩
Le CIC-1417 sur Twitter
Documents en texte intégral
70
Notices
67
Mots clés
Co-morbidities
Calcium phosphorus evaluation
DMD
Acute kidney injury
Internet
Misinformation
Innate immunity
Attitude to health
Immunocompromised
Attitude
Coronavirus
AON
Coadministration
Conditional marketing authorization
Vaccine safety and efficacy
Risk factors
Vaccine acceptance
B-lymphocytes
Attitudes
ANTIRETROVIRAL THERAPY
Disinformation
Influenza-like illness
Digital care
Digital health intervention
HIV
Hesitancy
Influenza
Epidemiology
Chronic kidney disease
Confidence
Care management
Determinant
Immunogenicity
Adjuvant
Sleep
Dose escalation
Conjugate pneumococcal vaccine
Adenoviral vector
Vaccine hesitancy
Cystic fibrosis
Elderly
Clinical skills
Antiviral agents
Awareness
Vaccine effectiveness
Vaccine
Adults
Clinical practice
Practices
Effectiveness
EHealth literacy
Respiratory syncytial virus
Covidom
Boys
Vaccines
Assay
Catch-up
Clinical research
Antiviral
France
COVID-19 vaccines
Biomarkers
SARS-CoV-2
Cohort study
Adverse effects
Efficacy
Booster response
1790GAHB F
Alpha variant
Incidence
Healthcare workers
Cohort
Antiviral therapy
Covid 19
HPV vaccine
Determinants
Déterminants
AIDS
EMA
COCONEL cohort surveys
COVID-19
Cancer
C-type lectin receptor
Covid-19
Delphi study
Dendritic cells
CERVICOVAGINAL SECRETIONS
Dialysis
Chemotherapy
Vaccination
Deletion
Attitudes of health personnel
Data sharing
Drug
Antiretroviral therapy
Cost of illness
AstraZeneca vaccine
Immunization
Diabetes mellitus type 2
Clinical trials